PSY12 the Cost of Treating Chronic Myeloid Leukemia (CML) in Greece

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.1735
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost-Utility Analysis of Bosutinib for Previously Treated Chronic Myeloid Leukemia (Cml) in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Cost-Effectiveness of Ponatinib in the Treatment of Patients With Accelerated or Blast Phase - Chronic Myeloid Leukemia in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Study to Assess the Pathophysiological Role of VEGF in Patients With Chronic Myeloid Leukemia(CML)

International Journal of Medical Science and Public Health
2013English

European LeukemiaNet 2020 Recommendations for Treating Chronic Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2020English

Disease Management and Treatment of Chronic Myeloid Leukemia (CML): Experience From the Patient (Pt) Perspective.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

What Is the Best Pharmacotherapeutic Strategy for Treating Chronic Myeloid Leukemia in the Elderly?

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2019English

Chronic Myeloid Leukemia

2020English

Chronic Myeloid Leukemia

Hematologic Malignancies
2016English

Autotransplants in Chronic Myeloid Leukemia

Oncologist
Cancer ResearchMedicineOncology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy